🇺🇸 FDA

Company profile · Sponsor

Medice

E6E228D · EMA pharma EU
Pipeline
3
Drugs
0
Patents
0

Quick answer

Medice (E6E228D) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E6E228D
Exchange EMA
Company type pharma
Headquarters EU

Frequently asked questions

What is Medice?

Medice (E6E228D) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Medice sponsor?

We track 3 ClinicalTrials.gov-linked programs for Medice, including Attentin 10 mg Tablette, Dexamfetamine sulfate 20 mg modified-release capsule, Placebo for Test 1 - 5 mg, Attentin 5 mg, Tablette, Placebo for test 2 - 10 mg, Placebo for test 1 - 10 mg, Placebo for test 2 - 20 mg, Dexamfetamine sulfate 15 mg modified-release capsule, Placebo for test 2 - 15 mg, Dexamfetamine sulfate 10 mg modified-release capsule and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Medice company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.